Stocks · Health care · Surgical & Medical Instruments & Apparatus

Beta Bionics, Inc.

BBNX Clue Score57
United States Fiscal year ends December CIK 0001674632 Results filed 27 Oct 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Mark Hopman
2 Nov 2026
Chief Commercial Officer
Sold on a plan
370
$16.90
$6.25K
Mike Mensinger
27 Oct 2026
Chief Product Officer
Sold on a plan
2,650
$22.00
$58.30K
Mark Hopman
26 Oct 2026
Chief Commercial Officer
Sold on a plan
821
$20.00
$16.42K
Christy Jones
22 Sep 2026
Director
Sold on a plan
6,430
$23.00
$147.89K
Mike Mensinger
16 Sep 2026
Chief Product Officer
Sold on a plan
2,650
$22.00
$58.30K
Mark Hopman
16 Sep 2026
Chief Commercial Officer
Sold on a plan
30,779
$20.13
$619.64K
Mark Hopman
14 Sep 2026
Chief Commercial Officer
Sold on a plan
775
$15.52
$12.03K
Mark Hopman
9 Sep 2026
Chief Commercial Officer
Sold on a plan
36,870
$18.46
$680.72K
Sean Saint
3 Sep 2026
President & CEO
Sold on a plan
5,641
$20.08
$113.26K
Christy Jones
24 Jun 2026
Director
Sold on a plan
1,406
$15.00
$21.09K
Mark Hopman
24 Jun 2026
Chief Commercial Officer
Sold on a plan
1,258
$15.01
$18.88K
Christy Jones
4 Jun 2026
Director
Sold on a plan
2,811
$14.00
$39.35K
Mark Hopman
4 Jun 2026
Chief Commercial Officer
Sold on a plan
275
$12.31
$3.39K
Adam Lezack
22 May 2026
Director
Sold on a plan
998
$11.21
$11.19K
Adam Lezack
21 May 2026
Director
Sold on a plan
1,000
$9.95
$9.95K
Christy Jones
21 May 2026
Director
Sold on a plan
1,998
$9.95
$19.88K
Mark Hopman
4 Mar 2026
Chief Commercial Officer
Sold on a plan
353
$11.57
$4.08K
Mike Mensinger
6 Jan 2026
Chief Product Officer
Sold on a plan
2,200
$30.10
$66.22K
Mike Mensinger
2 Jan 2026
Chief Product Officer
Sold on a plan
600
$30.20
$18.12K
Mike Mensinger
2 Jan 2026
Chief Product Officer
Sold on a plan
7,200
$29.56
$212.83K
Mark Hopman
4 Dec 2025
Chief Commercial Officer
Sold on a plan
2,061
$30.66
$63.19K
Mark Hopman
2 Dec 2025
Chief Commercial Officer
Sold on a plan
856
$29.34
$25.11K
Maria Palasis
1 Dec 2025
Director
Sold on a plan
500
$29.96
$14.98K
Maria Palasis
1 Dec 2025
Director
Sold on a plan
906
$29.33
$26.57K
Adam Lezack
1 Dec 2025
Director
Sold on a plan
500
$29.91
$14.96K
Adam Lezack
1 Dec 2025
Director
Sold on a plan
906
$29.35
$26.59K
Maria Palasis
31 Oct 2025
Director
Sold on a plan
119
$27.45
$3.27K
Maria Palasis
31 Oct 2025
Director
Sold on a plan
1,287
$26.86
$34.57K
Adam Lezack
31 Oct 2025
Director
Sold on a plan
38
$27.70
$1.05K
Adam Lezack
31 Oct 2025
Director
Sold on a plan
1,368
$26.85
$36.73K

What was left out

Form 4 filings counted 100
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 30
Sales straight out of an exercise 15
Sales at will 41
Transactions with no price 0
Shares from compensation/vesting 4,286,158
History held since 31 Jan 2025